Literature DB >> 18680273

Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication.

Venkat S R K Yedavalli1, Ning Zhang, Hongyi Cai, Peng Zhang, Matthew F Starost, Ramachandra S Hosmane, Kuan-Teh Jeang.   

Abstract

A series of ring expanded nucleoside (n class="Gene">REN) analogues were synthesized and screened for inhibition of cellular RNA helicase activity and human immunodeficiency virus type 1 (HIV-1) replication. We identified two compounds, 1 and 2, that inhibited the ATP dependent activity of human RNA helicase DDX3. Compounds 1 and 2 also suppressed HIV-1 replication in T cells and monocyte-derived macrophages. Neither compound at therapeutic doses was significantly toxic in ex vivo cell culture or in vivo in mice. Our findings provide proof-of-concept that a cellular factor, an RNA helicase, could be targeted for inhibiting HIV-1 replication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18680273      PMCID: PMC2537995          DOI: 10.1021/jm800332m

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  35 in total

Review 1.  Angiotensin-converting enzyme inhibitors.

Authors:  J Menard; A A Patchett
Journal:  Adv Protein Chem       Date:  2001

Review 2.  mRNA export: travelling with DEAD box proteins.

Authors:  P Linder; F Stutz
Journal:  Curr Biol       Date:  2001-11-27       Impact factor: 10.834

Review 3.  RNA chaperones exist and DEAD box proteins get a life.

Authors:  Jon R Lorsch
Journal:  Cell       Date:  2002-06-28       Impact factor: 41.582

Review 4.  A tale of two HSV-1 helicases: roles of phage and animal virus helicases in DNA replication and recombination.

Authors:  B Marintcheva; S K Weller
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001

5.  Knockdown of cellular RNA helicase DDX3 by short hairpin RNAs suppresses HIV-1 viral replication without inducing apoptosis.

Authors:  Musarat Ishaq; Jiajie Hu; Xiaoyun Wu; Qiong Fu; Yalin Yang; Qingzhen Liu; Deyin Guo
Journal:  Mol Biotechnol       Date:  2008-02-08       Impact factor: 2.695

6.  Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.

Authors:  James J Crute; Christine A Grygon; Karl D Hargrave; Bruno Simoneau; Anne-Marie Faucher; Gordon Bolger; Philip Kibler; Michel Liuzzi; Michael G Cordingley
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

7.  New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease.

Authors:  Gerald Kleymann; Rüdiger Fischer; Ulrich A K Betz; Martin Hendrix; Wolfgang Bender; Udo Schneider; Gabriele Handke; Peter Eckenberg; Guy Hewlett; Veniamin Pevzner; Judith Baumeister; Olaf Weber; Kerstin Henninger; Jörg Keldenich; Axel Jensen; Jörg Kolb; Ute Bach; Andreas Popp; Jutta Mäben; Isabelle Frappa; Dieter Haebich; Oswald Lockhoff; Helga Rübsamen-Waigmann
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

Review 8.  Adherence to HAART regimens.

Authors:  Margaret Chesney
Journal:  AIDS Patient Care STDS       Date:  2003-04       Impact factor: 5.078

9.  Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of hepatitis C and related viruses.

Authors:  Peter Borowski; Johanna Deinert; Sarah Schalinski; Maria Bretner; Krzysztof Ginalski; Tadeusz Kulikowski; David Shugar
Journal:  Eur J Biochem       Date:  2003-04

10.  The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in vivo.

Authors:  Miroslav S Sarac; Angus Cameron; Iris Lindberg
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.609

View more
  36 in total

1.  DDX3 regulates cell growth through translational control of cyclin E1.

Authors:  Ming-Chih Lai; Wen-Cheng Chang; Sheau-Yann Shieh; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2010-09-13       Impact factor: 4.272

Review 2.  RNA helicases: emerging roles in viral replication and the host innate response.

Authors:  Arnaz Ranji; Kathleen Boris-Lawrie
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

3.  Structure-based drug design and potent anti-cancer activity of tricyclic 5:7:5-fused diimidazo[4,5-d:4',5'-f][1,3]diazepines.

Authors:  Atul Kondaskar; Shilpi Kondaskar; James C Fishbein; Brandon A Carter-Cooper; Rena G Lapidus; Mariola Sadowska; Martin J Edelman; Ramachandra S Hosmane
Journal:  Bioorg Med Chem       Date:  2012-12-11       Impact factor: 3.641

Review 4.  Cellular RNA helicases and HIV-1: insights from genome-wide, proteomic, and molecular studies.

Authors:  Chia-Yen Chen; Xiang Liu; Kathleen Boris-Lawrie; Amit Sharma; Kuan-Teh Jeang
Journal:  Virus Res       Date:  2012-07-16       Impact factor: 3.303

5.  Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System.

Authors:  Atul Kondaskar; Shilpi Kondaskar; Raj Kumar; James C Fishbein; Nidal Muvarak; Rena G Lapidus; Mariola Sadowska; Martin J Edelman; Guus M Bol; Farhad Vesuna; Venu Raman; Ramachandra S Hosmane
Journal:  ACS Med Chem Lett       Date:  2010-12-31       Impact factor: 4.345

6.  Identification and analysis of inhibitors targeting the hepatitis C virus NS3 helicase.

Authors:  Alicia M Hanson; John J Hernandez; William R Shadrick; David N Frick
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

Review 7.  Insights into cellular factors that regulate HIV-1 replication in human cells.

Authors:  Andrew M L Lever; Kuan-Teh Jeang
Journal:  Biochemistry       Date:  2011-01-24       Impact factor: 3.162

8.  Dual inhibition of HCV and HIV by ring-expanded nucleosides containing the 5:7-fused imidazo[4,5-e][1,3]diazepine ring system. In vitro results and implications.

Authors:  Ning Zhang; Peng Zhang; Andrea Baier; Lucyna Cova; Ramachandra S Hosmane
Journal:  Bioorg Med Chem Lett       Date:  2014-01-08       Impact factor: 2.823

9.  Evolutionary constraints acting on DDX3X protein potentially interferes with Rev-mediated nuclear export of HIV-1 RNA.

Authors:  Deepak Sharma; Jayanta Bhattacharya
Journal:  PLoS One       Date:  2010-03-15       Impact factor: 3.240

Review 10.  What have RNAi screens taught us about viral-host interactions?

Authors:  Sara Cherry
Journal:  Curr Opin Microbiol       Date:  2009-07-01       Impact factor: 7.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.